We are live on ! Find out more
PCM

Penserra Capital Management Portfolio holdings

AUM $8.52B
1-Year Est. Return 37.76%
This Fund
S&P 500
This Quarter Est. Return
-5.08%
1 Year Est. Return
+37.76%
3 Year Est. Return
+116.32%
5 Year Est. Return
+122.1%
10 Year Est. Return
+1,892.45%
AUM
$4.82B
AUM Growth
-$690M
Cap. Flow
-$124M
Cap. Flow %
-2.58%
Top 10 Hldgs %
17.51%
Holding
1,588
New
254
Increased
693
Reduced
409
Closed
141

Sector Composition

Rank Sector Weight
1 Technology 27.8%
2 Consumer Discretionary 25.32%
3 Communication Services 11.6%
4 Industrials 6.01%
5 Financials 5.6%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ARQT icon
1201
Arcutis Biotherapeutics
ARQT
$3.18B
$27K ﹤0.01%
1,155
+10
+0.9% +$228
NRXP icon
1202
NRX Pharmaceuticals
NRXP
$153M
$27K ﹤0.01%
+296
New +$38.5K
SI
1203
DELISTED
Silvergate Capital Corporation
SI
$27K ﹤0.01%
+238
New +$25.5K
CCXI
1204
DELISTED
ChemoCentryx, Inc.
CCXI
$27K ﹤0.01%
1,600
+10
+0.6% +$156
EMN icon
1205
Eastman Chemical
EMN
$8.42B
$26K ﹤0.01%
264
+99
+60% +$10.9K
ENTA icon
1206
Enanta Pharmaceuticals
ENTA
$400M
$26K ﹤0.01%
460
FULC icon
1207
Fulcrum Therapeutics
FULC
$297M
$26K ﹤0.01%
925
+180
+24% +$3.41K
INVA icon
1208
Innoviva
INVA
$1.48B
$26K ﹤0.01%
1,590
+10
+0.6% +$150
KRYS icon
1209
Krystal Biotech
KRYS
$9.66B
$26K ﹤0.01%
510
+5
+1% +$296
SRRK icon
1210
Scholar Rock
SRRK
$6.44B
$26K ﹤0.01%
790
+5
+0.6% +$175
USB icon
1211
US Bancorp
USB
$99.6B
$26K ﹤0.01%
438
+103
+31% +$5.87K
IMGN
1212
DELISTED
Immunogen Inc
IMGN
$26K ﹤0.01%
4,630
+80
+2% +$462
RNAM
1213
DELISTED
Avidity Biosciences
RNAM
$25K ﹤0.01%
1,040
+185
+22% +$4.02K
TSN icon
1214
Tyson Foods
TSN
$20.4B
$25K ﹤0.01%
318
+88
+38% +$6.64K
FMTX
1215
DELISTED
Forma Therapeutics Holdings, Inc. Common Stock
FMTX
$25K ﹤0.01%
1,085
+5
+0.5% +$118
AWR icon
1216
American States Water
AWR
$3.46B
$24K ﹤0.01%
282
+26
+10% +$2.29K
MNKD icon
1217
MannKind Corp
MNKD
$1.32B
$24K ﹤0.01%
5,710
+40
+0.7% +$180
DFAE icon
1218
Dimensional Emerging Core Equity Market ETF
DFAE
$9.7B
$23K ﹤0.01%
+868
New +$24.5K
DFAI
1219
Dimensional International Core Equity Market ETF
DFAI
$18B
$23K ﹤0.01%
+824
New +$24.4K
ECL icon
1220
Ecolab
ECL
$79.9B
$23K ﹤0.01%
114
+29
+34% +$6.36K
LH icon
1221
Labcorp
LH
$25.9B
$23K ﹤0.01%
98
+11
+13% +$2.77K
PGEN icon
1222
Precigen
PGEN
$2.59B
$23K ﹤0.01%
4,725
+25
+0.5% +$144
TROW icon
1223
T. Rowe Price
TROW
$24.3B
$23K ﹤0.01%
120
+5
+4% +$1.05K
VIRT icon
1224
Virtu Financial
VIRT
$4.93B
$23K ﹤0.01%
+970
New +$24.6K
MILE
1225
DELISTED
Metromile, Inc. Common Stock
MILE
$23K ﹤0.01%
6,606
-10,060
-60% -$56.8K

Similar funds

Penserra Capital Management's Q3 2021 Portfolio in Review

As of Q3 2021, Penserra Capital Management held 1,588 positions worth $4.82B, down 13% from $5.51B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

Penserra Capital Management's Q3 2021 filing shows 254 new, 693 increased, 409 reduced and 141 closed positions. Its largest new stake was DiDi Global Inc. American depositary shares, each four representing one Class A ordinary share: 5,364,893 shares worth $41.8M. The largest sale was Baidu, an estimated $24.6M.

By sector, the portfolio is most concentrated in Technology at 28% of assets, up from 25% a quarter earlier, followed by Consumer Discretionary and Communication Services.

  • Penserra Capital Management's largest Q3 2021 buy was DiDi Global Inc. American depositary shares, each four representing one Class A ordinary share: 5,364,893 shares worth $41.8M.
  • Penserra Capital Management added most to Analog Devices in Q3 2021, an estimated $22.8M increase.
  • Penserra Capital Management's biggest Q3 2021 reduction was Baidu, cutting an estimated $24.6M.
  • Penserra Capital Management fully exited BlackRock Resources & Commodities Strategy Trust in Q3 2021, selling an estimated $22.3M.
  • Penserra Capital Management's ten largest holdings make up 18% of its $4.82B portfolio in Q3 2021.
  • Penserra Capital Management opened 254 new positions and closed 141 in Q3 2021.
  • Penserra Capital Management's portfolio value fell 13% quarter-over-quarter to $4.82B.

Based on Penserra Capital Management's 13F filing for Q3 2021, filed 15 Nov 2021.